CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Using ETFs for portfolio diversification is an effective strategy for investors. Learn how they can help achieve a balanced and cost-effective portfolio.
19,111 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Arista Networks stock flew higher on Friday, climbing more than 4% on a fresh analyst upgrade. This article breaks do...
Two heavyweight paths in AI CPUs shape the next decade of computing. This article breaks down how Advanced Micro Devi...
Supermicro sits at the intersection of exploding AI demand and serious credibility concerns. This article breaks down...
Realty Income reports steady AFFO growth, near-full occupancy, and a secure monthly dividend, challenging the narrati...
PepsiCo trims snack prices in North America to spur demand, but the pause in regional growth keeps investors focused ...
SoftBank CEO Masayoshi Son says global AI demand will need roughly $5 trillion each year to scale infrastructure, arg...
A fresh group of stocks tied to memory chips is redefining global markets as AI data centers push demand higher. The ...
Resolute Holdings stock soars can signal a potent momentum move. This guide breaks down the drivers, evaluates sustai...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
OpenAI is in talks with the U.S. Department of Defense on a potential AI services contract, with safeguards and deplo...
Circle stock jumped february as investors weighed an earnings beat against a choppy crypto backdrop. This article unp...